208 related articles for article (PubMed ID: 18571586)
1. Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat.
Buyne OR; van Goor H; Bleichrodt RP; Verweij PE; Hendriks T
Surgery; 2008 Jul; 144(1):66-73. PubMed ID: 18571586
[TBL] [Abstract][Full Text] [Related]
2. Timing and dose of tissue plasminogen activator to prevent abscess formation after surgical treatment of secondary peritonitis in the rat.
Buyne OR; van Goor H; Verweij PE; Bleichrodt RP; Hendriks T
Surg Innov; 2009 Dec; 16(4):299-305. PubMed ID: 20031941
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator, but not systemic antibiotic therapy, prevents abscess formation in an experimental model of secondary peritonitis.
Buyne OR; Bleichrodt RP; van Goor H; Verweij PE; Hendriks T
Br J Surg; 2008 Oct; 95(10):1287-93. PubMed ID: 18720460
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP
J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389
[TBL] [Abstract][Full Text] [Related]
5. Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator.
van Goor H; de Graaf JS; Kooi K; Bleichrodt RP
J Am Coll Surg; 1995 Jul; 181(1):38-42. PubMed ID: 7599769
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model.
Buyne OR; Bleichrodt RP; van Goor H; Verweij PE; Hendriks T
Int J Colorectal Dis; 2007 Jul; 22(7):819-25. PubMed ID: 17089129
[TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator prevents abscess formation but does not affect healing of bowel anastomoses and laparotomy wounds in rats with secondary peritonitis.
Buyne OR; Bleichrodt RP; De Man BM; Lomme RM; Verweij PE; van Goor H; Hendriks T
Surgery; 2009 Nov; 146(5):939-46. PubMed ID: 19744456
[TBL] [Abstract][Full Text] [Related]
8. Prevention of intraperitoneal adhesions and abscesses by polysaccharides isolated from Phellinus spp in a rat peritonitis model.
Bae JS; Ahn SJ; Yim H; Jang KH; Jin HK
Ann Surg; 2005 Mar; 241(3):534-40. PubMed ID: 15729079
[TBL] [Abstract][Full Text] [Related]
9. Effects of the intraperitoneal lornoxicam on the formation of intraperitoneal adhesions in rat peritonitis model.
Bulbuloglu E; Ezberci F; Gul M; Kurutas EB; Bozkurt S; Kale IT; Ciragil P
ANZ J Surg; 2005 Dec; 75(12):1115-9. PubMed ID: 16398822
[TBL] [Abstract][Full Text] [Related]
10. Time course of peritoneal tissue plasminogen activator after experimental colonic surgery: effect of hyaluronan-based antiadhesive agents and bacterial peritonitis.
Reijnen MM; Holmdahl L; Kooistra T; Falk P; Hendriks T; van Goor H
Br J Surg; 2002 Jan; 89(1):103-9. PubMed ID: 11851673
[TBL] [Abstract][Full Text] [Related]
11. Auto-cross-linked hyaluronic acid gel does not reduce intra-abdominal adhesions or abscess formation in a rat model of peritonitis.
Sikkink CJ; de Man B; Bleichrodt RP; van Goor H
J Surg Res; 2006 Dec; 136(2):255-9. PubMed ID: 17059836
[TBL] [Abstract][Full Text] [Related]
12. Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis.
Tong MK; Leung KT; Siu YP; Lee KF; Lee HK; Yung CY; Kwan TH; Au TC
J Nephrol; 2005; 18(2):204-8. PubMed ID: 15931649
[TBL] [Abstract][Full Text] [Related]
13. [Behavior of postoperative adhesions after intraperitoneal administration of fibrinolytic drugs in a rat model].
Stapel A; Geissler N; Mlasowsky B; Jung D
Langenbecks Arch Chir; 1997; 382(1):33-6. PubMed ID: 9157230
[TBL] [Abstract][Full Text] [Related]
14. Local release of fibrinolytic agents for adhesion prevention.
Hill-West JL; Dunn RC; Hubbell JA
J Surg Res; 1995 Dec; 59(6):759-63. PubMed ID: 8538178
[TBL] [Abstract][Full Text] [Related]
15. Effects of tissue plasminogen activator in experimentally induced peritonitis.
Erginel B; Oksüz L; Erginel T; Gün F; Yanar F; Gürler N; Salman T; Celik A
Ulus Travma Acil Cerrahi Derg; 2014 Jan; 20(1):7-11. PubMed ID: 24639308
[TBL] [Abstract][Full Text] [Related]
16. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
17. Administration of honey to prevent peritoneal adhesions in a rat peritonitis model.
Yuzbasioglu MF; Kurutas EB; Bulbuloglu E; Goksu M; Atli Y; Bakan V; Kale IT
Int J Surg; 2009 Feb; 7(1):54-7. PubMed ID: 19042166
[TBL] [Abstract][Full Text] [Related]
18. Prevention of intra-abdominal abscesses with fibrinolytic agents.
Rosenthal GA; Quinto J; Kao J; Rotstein OD
Can J Surg; 1988 Mar; 31(2):98-100. PubMed ID: 3127033
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model.
van Goor H; Bom VJ; van der Meer J; Sluiter WJ; Geerards S; van der Schaaf W; de Graaf JS; Bleichrodt RP
Eur Surg Res; 1996; 28(4):287-94. PubMed ID: 8813653
[TBL] [Abstract][Full Text] [Related]
20. The effects of minidose heparin and low molecular weight heparin on peritonitis in the rat.
Vela AR; Littleton JC; O'Leary JP
Am Surg; 1999 May; 65(5):473-7. PubMed ID: 10231222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
